A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-10-12) →
What happened
L&C BIO disclosed a new share issuance to raise US$99M, about 10.0% of its market value.
For context, this raise equals about 10.0% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$99M |
| vs. market value | 10.0% |
| Filed | 2026-07-31, Material event report (paid-in and bonus issue) |
| Source | DART rcept 20260731000522 → open original filing |
Versions of this filing
- 2026-07-31Original (this page)
- 2026-09-02Amendment 1
- 2026-10-12Amendment 2
Source: DART. Information only, not investment advice.